LABCORP HOLDINGS INC.

Labcorp (LH) announced a quarterly cash dividend of $0.72 per share, payable June 11, 2025 [1], [9]. The company is focusing on specialty testing and strategic acquisitions for growth, particularly in oncology and women's health [2]. They launched a new blood test for Alzheimer's, potentially increasing market share in diagnostics [3], and expanded access to at-home HPV and STI testing [5]. While Q4 2024 revenue grew by 9.8%, it lagged behind competitors [6]. Despite macroeconomic headwinds and sector downturn, Labcorp's focus on growth areas, acquisitions, and new test offerings suggests a positive long-term outlook, though competition remains a risk [2], [3].